New Guidelines for Screening, Evaluation and Management of Hepatobiliary Disease in Cystic Fibrosis

Overview

Journal Hepatobiliary Surg Nutr

Publisher AME Publishing Company

Date 2024 Nov 7

PMID 39507715

Authors

P Aiden McCormick

Emer Fitzpatrick

Affiliations

Soon will be listed here.

References

Leung D, Ye W, Schwarzenberg S, Freeman A, Palermo J, Weymann A . Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study. J Cyst Fibros. 2022; 22(2):248-255. DOI: 10.1016/j.jcf.2022.07.017. View

Sokol R, Durie P . Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr. 1999; 28 Suppl 1:S1-13. DOI: 10.1097/00005176-199900001-00001. View

Hermie L, Van Biervliet S, Hoorens A, Van Cauwenberghe L, Robberecht E, Defreyne L . Pre-emptive transjugular intrahepatic portosystemic shunt in pediatric cystic fibrosis-related liver disease and portal hypertension: prospective long-term results. Diagn Interv Radiol. 2023; 30(1):55-64. PMC: 10773179. DOI: 10.4274/dir.2022.221818. View

Rowland M, McGee A, Broderick A, Drumm B, Connolly L, Daly L . Repeatability of transient elastography in children. Pediatr Res. 2020; 88(4):587-592. DOI: 10.1038/s41390-020-0916-4. View

OBrien C, Ramlaul N, Haughey A, Nolan N, Malone D, McCormick P . Hepatocellular carcinoma in cystic fibrosis liver disease: a cautionary tale. QJM. 2019; 112(9):693-694. DOI: 10.1093/qjmed/hcz150. View

Sellers Z, Assis D, Paranjape S, Sathe M, Bodewes F, Bowen M . Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations. Hepatology. 2023; 79(5):1220-1238. PMC: 11020118. DOI: 10.1097/HEP.0000000000000646. View

Wu H, Vu M, Dhingra S, Ackah R, Goss J, Rana A . Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension. Clin Gastroenterol Hepatol. 2018; 17(10):2134-2136. DOI: 10.1016/j.cgh.2018.10.046. View

Rowland M, Drummond J, Connolly L, Daly E, McCormick P, Bourke B . The natural history of cystic fibrosis liver disease a prospective cohort study. J Cyst Fibros. 2023; 22(6):1054-1061. DOI: 10.1016/j.jcf.2023.07.002. View

Klotter V, Gunchick C, Siemers E, Rath T, Hudel H, Naehrlich L . Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study. PLoS One. 2017; 12(6):e0178784. PMC: 5456384. DOI: 10.1371/journal.pone.0178784. View

10.

Witters P, Libbrecht L, Roskams T, De Boeck K, Dupont L, Proesmans M . Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension. J Cyst Fibros. 2017; 16(5):e11-e13. DOI: 10.1016/j.jcf.2017.03.006. View

11.

De Gottardi A, Rautou P, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J . Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol. 2019; 4(5):399-411. DOI: 10.1016/S2468-1253(19)30047-0. View

12.

Bodewes F, Freeman A, Weymann A, Debray D, Scheers I, Verkade H . Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper. J Pediatr Gastroenterol Nutr. 2024; 78(1):153-165. DOI: 10.1097/MPG.0000000000003944. View